Abstract
Intravenous durvalumab (Imfinzi (TM); AstraZeneca) is a fully human monoclonal antibody that blocks programmed cell death ligand-1 binding to its rece......
小提示：本篇文献需要登录阅读全文，点击跳转登录
Full Text Link
